journal article·2024-11

Targeted treatment of kidney using intravenous and intraarterial delivery of whey protein isolate-based microgels

Olga A. Sindeeva, Daria A. Terentyeva, Mariia S. Saveleva, Olga I. Gusliakova, Ekaterina S. Prikhozhdenko, Oleg A. Kulikov, Dmitry A. Gorin, Oksana A. Mayorova

Optical Materials· Volume 157
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Dialysis and Renal Disease Management · Biomedical Research and Pathophysiology · Genetic and Kidney Cyst Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy10.1016/S0140-6736(17)30788-2 ↗
2. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients10.1097/01.ASN.0000127045.14709.75 ↗
3. Cardiovascular disease and subsequent kidney disease10.1001/archinte.167.11.1130 ↗
4. Risk factors for chronic kidney disease: an update10.1038/kisup.2013.79 ↗
5. Kidney injury in liver disease10.1016/j.ccc.2016.03.005 ↗
6. Targeted drug delivery systems for kidney diseases10.3389/fbioe.2021.683247 ↗
7. Advanced drug delivery systems for renal disorders10.3390/gels9020115 ↗
8. Intravesical delivery of 5‐aminolevulinic acid from water‐in‐oil nano/submicron‐emulsion systems
9. Mucoadhesive emulsion microgels for intravesical drug delivery: preparation, retention at urothelium, and biodistribution study10.1021/acsami.3c02741 ↗
10. Solid-in-Oil-in-Water emulsion: an innovative paradigm to improve drug stability and biological activity10.1208/s12249-021-02074-y ↗
11. Particle-stabilized oil-in-water emulsions as a platform for topical lipophilic drug delivery10.1016/j.colsurfb.2020.111423 ↗
12. Encapsulation properties, release behavior and physicochemical characteristics of water-in-oil-in-water (W/O/W) emulsion stabilized with pectin–pea protein isolate conjugate and Tween 8010.1016/j.foodhyd.2016.06.023 ↗
13. An overview of drug delivery systems10.1007/978-1-4939-9798-5_1 ↗
14. Endovascular addressing improves the effectiveness of magnetic targeting of drug carrier. Comparison with the conventional administration method10.1016/j.nano.2020.102184 ↗
15. Target delivery of drug carriers in mice kidney glomeruli via renal artery. Balance between efficiency and safety10.1016/j.jconrel.2020.11.051 ↗
16. Renal artery catheterization for microcapsules' targeted delivery to the mouse kidney10.3390/pharmaceutics14051056 ↗
17. Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy10.1016/j.jconrel.2022.08.015 ↗
18. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
19. Processing of whey from dairy industry waste10.1007/s10311-005-0108-9 ↗
20. The stability of whey protein-stabilized red palm oil emulsion from a rheological perspective10.35219/foodtechnology.2022.2.03 ↗
21. Rheological fingerprinting and tribological assessment of high internal phase emulsions stabilized by whey protein isolate: effects of protein concentration and pH10.1016/j.foodhyd.2022.107816 ↗
22. Interfacial properties of whey protein and whey protein hydrolysates and their influence on O/W emulsion stability10.1016/j.foodhyd.2017.06.001 ↗
23. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants10.1080/21645515.2015.1046660 ↗
24. Effective droplet size reduction and excellent stability of limonene nanoemulsion formed by high-pressure homogenizer10.3390/colloids4010005 ↗
25. Impact of ultrasonic treatment on an emulsion system stabilized with soybean protein isolate and lecithin: its emulsifying property and emulsion stability10.1016/j.foodhyd.2016.10.024 ↗
26. Understanding how the properties of whey protein stabilized emulsions depend on pH, ionic strength and calcium concentration, by mapping environmental conditions to zeta potential10.1016/j.foodhyd.2017.12.003 ↗
27. Soy/whey protein isolates: interfacial properties and effects on the stability of oil‐in‐water emulsions10.1002/jsfa.10638 ↗
28. Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation10.1194/jlr.M064089 ↗
29. Spectroscopic investigation on the interaction of a cyanine dye with serum albumins10.1002/cjoc.200890076 ↗
30. Symmetric meso-chloro-substituted pentamethine cyanine dyes containing benzothiazolyl/benzoselenazolyl chromophores novel synthetic approach and studies on photophysical properties upon interaction with bio-objects10.1007/s10895-015-1700-4 ↗
31. Photophysical characterization and BSA interaction of the direct ring carboxy functionalized unsymmetrical NIR cyanine dyes10.1016/j.dyepig.2017.01.015 ↗
32. Macrophage in vitro and in vivo tracking via anchored microcapsules10.1021/acsami.2c12004 ↗
33. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis10.3390/ijms19010092 ↗
34. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion10.1016/S0091-6749(03)80114-8 ↗
35. Of macrophages and red blood cells; a complex love story10.3389/fphys.2014.00009 ↗
36. Intracellular protein catabolism: state of the art10.1016/0014-5793(86)80403-3 ↗
37. O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection10.3109/10611869808997887 ↗
38. Injectable lipid emulsions—advancements, opportunities and challenges10.1208/s12249-010-9526-5 ↗
39. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice10.1016/j.ijpharm.2006.05.008 ↗
40. Comparison of embolic effect between water‐in‐oil emulsion and microspheres in transarterial embolization for rat hepatocellular carcinoma model10.1111/hepr.13561 ↗
41. Janus particle-engineered structural lipiodol droplets for arterial embolization10.1038/s41467-023-41322-6 ↗
42. Safety of high volume lipid emulsion infusion10.1097/AAP.0b013e3181c6f5aa ↗
43. Lipid injectable emulsions: pharmacopeial and safety issues10.1007/s11095-006-9092-4 ↗